دورية أكاديمية
Nab-paclitaxel/gemcitabine combination is more effective than gemcitabine alone in locally advanced, unresectable pancreatic cancer - A GISCAD phase II randomized trial
| العنوان: | Nab-paclitaxel/gemcitabine combination is more effective than gemcitabine alone in locally advanced, unresectable pancreatic cancer - A GISCAD phase II randomized trial |
|---|---|
| المؤلفون: | Cascinu, Stefano, Berardi, Rossana, Bianco, Roberto, Bilancia, Domenico, Zaniboni, Alberto, Ferrari, Daris, Mosconi, Stefania, Spallanzani, Andrea, Cavanna, Luigi, Leo, Silvana, Negri, Francesca, Beretta, Giordano D, Sobrero, Alberto, Banzi, Maria, Morabito, Alberto, Bittoni, Alessandro, Marciano, Roberta, Ferrara, Domenica, Noventa, Silvia, Piccirillo, Maria C, Labianca, Roberto, Mosconi, Cristina, Casadei Gardini, Andrea, Gallo, Ciro, Perrone, Francesco |
| المساهمون: | Cascinu, Stefano, Berardi, Rossana, Bianco, Roberto, Bilancia, Domenico, Zaniboni, Alberto, Ferrari, Dari, Mosconi, Stefania, Spallanzani, Andrea, Cavanna, Luigi, Leo, Silvana, Negri, Francesca, Beretta, Giordano D, Sobrero, Alberto, Banzi, Maria, Morabito, Alberto, Bittoni, Alessandro, Marciano, Roberta, Ferrara, Domenica, Noventa, Silvia, Piccirillo, Maria C, Labianca, Roberto, Mosconi, Cristina, Casadei Gardini, Andrea, Gallo, Ciro, Perrone, Francesco |
| سنة النشر: | 2021 |
| المجموعة: | IRIS Università degli Studi di Napoli Federico II |
| مصطلحات موضوعية: | Advanced pancreatic cancer, Paclitaxel and gemcitabine, Phase II randomized trial, Adenocarcinoma, Adult, Aged, Albumin, Antineoplastic Combined Chemotherapy Protocol, Deoxycytidine, Female, Follow-Up Studie, Human, Male, Middle Aged, Paclitaxel, Pancreatic Neoplasm, Prognosi, Survival Rate |
| الوصف: | The role of combination chemotherapy has not yet been established in unresectable locally advanced pancreatic cancer (LAPC) lacking dedicated randomized trials. |
| نوع الوثيقة: | article in journal/newspaper |
| اللغة: | English |
| العلاقة: | info:eu-repo/semantics/altIdentifier/wos/WOS:000644993500009; volume:148; firstpage:422; lastpage:429; numberofpages:8; journal:EUROPEAN JOURNAL OF CANCER; http://hdl.handle.net/11588/890495Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85105007363; https://pubmed.ncbi.nlm.nih.gov/33812334Test/ |
| DOI: | 10.1016/j.ejca.2021.02.023 |
| الإتاحة: | https://doi.org/10.1016/j.ejca.2021.02.023Test http://hdl.handle.net/11588/890495Test https://pubmed.ncbi.nlm.nih.gov/33812334Test/ |
| حقوق: | info:eu-repo/semantics/openAccess |
| رقم الانضمام: | edsbas.4F6A6996 |
| قاعدة البيانات: | BASE |
| DOI: | 10.1016/j.ejca.2021.02.023 |
|---|